Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients

Omeprazole Significantly Reduces Posaconazole Serum Trough Level

(2009) Jan‐Willem C. Alffenaar et al.   CLINICAL INFECTIOUS DISEASES

Cystic fibrosis

(2009) Brian P O'Sullivan et al.   LANCET

Therapeutic Drug Monitoring of Antifungals: Pharmacokinetic and Pharmacodynamic Considerations

(2009) Jeannina Smith et al.   THERAPEUTIC DRUG MONITORING

Safe Management of Tacrolimus Together With Posaconazole in Lung Transplant Patients With Cystic Fibrosis

(2009) Maud Berge et al.   THERAPEUTIC DRUG MONITORING

Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients

(2009) M. Berge et al.   Transplant Infectious Disease

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Therapeutic drug monitoring for triazoles

(2008) William W Hope et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Neuromuscular Painful Disorders: a Rare Side Effect of Voriconazole in Lung Transplant Patients Under Tacrolimus

(2008) V. Boussaud et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES